|
Lilly’s Oral GLP-1 Falls Short of Expectations, Boosting Novo Nordisk
|
Written by: J. Smith |
Hits: 243
|
|
Mounjaro Shows Heart Health Potential in Landmark Diabetes Trial
|
Written by: J. Smith |
Hits: 161
|
|
Novo Nordisk Lowers Outlook, Names New CEO, and Restructures R&D
|
Written by: J. Smith |
Hits: 254
|
|
Genetic Test Predicts Obesity Risk in Early Childhood
|
Written by: J. Smith |
Hits: 194
|
|
Novo Nordisk Ends Partnership with Hims & Hers Over Safety Concerns
|
Written by: J. Smith |
Hits: 174
|
|
Lilly’s Once-Daily Oral GLP-1 Pill Shows Promise for Type 2 Diabetes
|
Written by: J. Smith |
Hits: 266
|
|
Dexcom Issues Updated Device Correction Notice for G6 and G7 Receivers Following FDA Recall
|
Written by: J. Smith |
Hits: 234
|
|
Lilly Adds High-Dose Zepbound to Self-Pay Program, Expands Access to All Approved Strengths
|
Written by: J. Smith |
Hits: 351
|
|
Insulet Launches Omnipod 5 iPhone App with Dexcom G7 Integration for All U.S. Users
|
Written by: J. Smith |
Hits: 175
|
|
Denmark Launches Ambitious Heart Disease Study with Record-Breaking Grant
|
Written by: J. Smith |
Hits: 219
|
